Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48.9M
-
Number of holders
-
290
-
Total 13F shares, excl. options
-
37.2M
-
Shares change
-
-1.56M
-
Total reported value, excl. options
-
$3.15B
-
Value change
-
-$143M
-
Put/Call ratio
-
0.63
-
Number of buys
-
139
-
Number of sells
-
-129
-
Price
-
$84.61
Significant Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2024
370 filings reported holding AXSM - Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q4 2024.
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) has 290 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.2M shares
of 48.9M outstanding shares and own 75.97% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (4.05M shares), VANGUARD GROUP INC (3.9M shares), BlackRock, Inc. (3.53M shares), Fairmount Funds Management LLC (1.47M shares), BVF INC/IL (1.39M shares), FMR LLC (1M shares), RA CAPITAL MANAGEMENT, L.P. (1M shares), MACQUARIE GROUP LTD (964K shares), STATE STREET CORP (947K shares), and GEODE CAPITAL MANAGEMENT, LLC (913K shares).
This table shows the top 290 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.